A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris
NCT ID: NCT00663286
Last Updated: 2008-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
1399 participants
INTERVENTIONAL
2006-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
IDP-110
Topical application for 12 weeks
2
Clindamycin
Topical application for 12 weeks
3
Benzoyl peroxide
Topical application for 12 weeks
4
Vehicle
Topical application for 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IDP-110
Topical application for 12 weeks
Clindamycin
Topical application for 12 weeks
Benzoyl peroxide
Topical application for 12 weeks
Vehicle
Topical application for 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Female subjects who are pregnant, nursing, planning a pregnancy, or become pregnant during the study
12 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dow Pharmaceutical Sciences
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dow Pharmaceutical Sciences, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Burke Pharmaceutical Research
Hot Springs, Arkansas, United States
The Savin Center, PC
New Haven, Connecticut, United States
Webster Dermatology, PA
Hockessin, Delaware, United States
Skin Care Research, Inc.
Boca Raton, Florida, United States
Advanced Dermatology and Cosmetic Surgery
Clermont, Florida, United States
North Florida Dermatology Associates, PA
Jacksonville, Florida, United States
Advanced Dermatology and Cosmetic Surgery
Ormond Beach, Florida, United States
Dermatology Research
Pinellas Park, Florida, United States
Florida Dermatology Institute
West Palm Beach, Florida, United States
Derm Center of Augusta
Augusta, Georgia, United States
MedaPhase Inc.
Newnan, Georgia, United States
Gwinnett Clinical Research Center, Inc.
Snellville, Georgia, United States
DuPage Medical Group
Naperville, Illinois, United States
Hudson Dermatology
Evansville, Indiana, United States
South Bend Clinic
South Bend, Indiana, United States
Dermatology Specialists Research
Louisville, Kentucky, United States
Michigan Center for Research Corp.
Clinton Township, Michigan, United States
Minnesota Clinical Study Center
Fridley, Minnesota, United States
SUNY Downstate Medical Center
Brooklyn, New York, United States
Atlantic Dermatologic Associates, LLP
Brooklyn, New York, United States
Office of Fran E. Cook-Bolden, MD
New York, New York, United States
Helendale Dermatology and Medical Spa
Rochester, New York, United States
Dermatology Associates of Rochester
Rochester, New York, United States
DermResearch Center of New York
Stony Brook, New York, United States
Central Sooner Research
Norman, Oklahoma, United States
Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
DermResearch, Inc.
Austin, Texas, United States
J & S Studies, Inc.
Bryan, Texas, United States
Thomas J. Stephens & Associates
Carrollton, Texas, United States
Dallas Associated Dermatologists
Dallas, Texas, United States
Education & Research Foundation
Lynchburg, Virginia, United States
Virginia Clinical Research, Inc
Norfolk, Virginia, United States
Madison Skin & Research, Inc.
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DPSI-06-22-2006-017
Identifier Type: -
Identifier Source: org_study_id